Equities

Linike Medical Group Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
LNMG:PKC

Linike Medical Group Ltd

Actions
  • Price (USD)0.0257
  • Today's Change0.00 / 0.00%
  • Shares traded28.00k
  • 1 Year change-71.50%
  • Beta--
Data delayed at least 15 minutes, as of Feb 05 2026 14:49 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Linike Medical Group Ltd is engaged in research and development (R&D), production and sales of external beam therapy equipment-medical electron linear accelerator, used for treating cancers. The Company focused on selling and marketing various types of floor coverings, namely, hardwood, engineered, and laminates to the local market. The Company’s subsidiaries include China Linike Medical Group Ltd, Sichuan Huarong Zhengtai Medical Technology Co., Ltd and Chengdu Linike Medical Technology Development Co., Ltd.

  • Revenue in USD (TTM)0.00
  • Net income in USD-306.90k
  • Incorporated2011
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
NuCana PLC (ADR)0.00-37.56m15.20m20.00--0.4296-----7,212.13-7,212.130.004.930.00----0.00-106.16-47.75-180.13-58.87-----------1.590.0052------31.25---25.32--
Traws Pharma Inc2.85m93.35m15.34m7.000.0683.01--5.3928.2428.240.45660.63730.2662--1.38406,571.40-124.51-151.85-517.46-207.35-----467.64-21,652.42----0.00--0.00-36.47-188.55------
P3 Health Partners Inc1.44bn-131.05m15.42m360.00------0.0107-40.18-40.18442.85-5.721.91--14.074,013,756.00-37.78-49.89-113.11-253.77-4.05-1.15-19.83-46.73---5.360.9304--18.4859.38-135.14------
Apimeds Pharmaceuticals US Inc0.00-5.16m15.47m2.00--1.90-----0.4762-0.47620.000.64890.00----0.00-111.07---138.71-------------162.300.0577-------78.73------
Citius Pharmaceuticals Inc0.00-37.43m15.89m23.00--0.2047-----3.84-3.840.003.740.00----0.00-32.10-29.86-52.00-35.19--------0.1257-244.300.0127------6.85--400.55--
Klotho Neurosciences Inc0.00-11.29m16.24m3.00--1.57-----0.3264-0.32640.000.14110.00----0.00-180.10---197.00-------------1.900.00-------556.89------
Pasithea Therapeutics Corp0.00-13.49m16.40m4.00--0.433-----5.21-5.210.001.640.00----0.00-83.64---89.28--------------0.00------10.34------
Fibrobiologics Inc0.00-18.50m16.70m13.00--96.91-----0.4809-0.48090.000.00260.00----0.00-192.59---636.43-------------27.090.9734------41.44------
LeonaBio Inc0.00-37.72m17.12m26.00--0.639-----9.68-9.680.006.790.00----0.00-64.88-36.31-87.99-38.92------------0.00------17.62------
Linike Medical Group Ltd0.00-306.90k17.16m-----------0.1102-0.11020.00-0.1530.00-------278.62---------------------------651.26------
Lunai Bioworks Inc0.00-130.98m17.21m29.00---------7.51-7.510.00-0.56260.00----0.00-203.39-75.79-304.47-85.18-----------28.85---------101.31------
IN8bio Inc0.00-20.66m17.38m18.00--0.6194-----6.48-6.480.002.870.00----0.00-126.22-79.60-150.81-91.19------------0.0299-------1.43---10.74--
Lixte Biotechnology Holdings Inc0.00-4.13m17.40m2.00--7.38-----1.18-1.180.000.86120.00----0.00-114.55-113.03-130.06-121.30-----------1,017.390.00------29.51------
Phio Pharmaceuticals Corp0.00-7.95m17.76m5.00--0.9701-----2.73-2.730.001.700.00----0.00-91.57-73.65-107.58-86.34------------0.00------33.96---57.49--
Vyne Therapeutics Inc524.00k-33.79m18.97m13.00--0.5644--36.21-0.7917-0.78880.01231.010.0093----40,307.69-60.16-107.54-70.67-136.47-----6,448.47-1,720.83----0.00--18.16---42.82--60.46--
Data as of Feb 05 2026. Currency figures normalised to Linike Medical Group Ltd's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.